blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0699666

EP0699666 - Heterocyclic substituted benzoylguanidine [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.11.1999
Database last updated on 11.09.2024
Most recent event   Tooltip12.11.1999No opposition filed within time limitpublished on 29.12.1999 [1999/52]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[N/P]
Former [1999/01]For all designated states
MERCK PATENT GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
Former [1996/10]For all designated states
MERCK PATENT GmbH
Frankfurter Strasse 250
D-64293 Darmstadt / DE
Inventor(s)01 / Gericke, Rolf, Dr.
Mozartstrasse 19
D-64342 Seeheim-Jugenheim / DE
02 / Dorsch, Dieter, Dr.
Königsberger Strasse 171
D-64372 Ober-Ramstadt / DE
03 / Baumgarth, Manfred, Dr.
Sachsenstrasse 53
D-64297 Darmstadt / DE
04 / Minck, Klaus-Otto, Dr.
Büchestrasse 8
D-64372 Ober Ramstadt / DE
05 / Beier, Norbert, Dr.
Georgenhäuser Strasse 19
D-64354 Reinheim / DE
[1996/10]
Application number, filing date95113307.324.08.1995
[1996/10]
Priority number, dateDE1994443086131.08.1994         Original published format: DE 4430861
[1996/10]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0699666
Date:06.03.1996
Language:DE
[1996/10]
Type: B1 Patent specification 
No.:EP0699666
Date:07.01.1999
Language:DE
[1999/01]
Search report(s)(Supplementary) European search report - dispatched on:EP04.01.1996
ClassificationIPC:C07D233/60, C07D213/56, C07D213/68, C07D295/155, C07D211/58, C07D211/42, C07D207/327, C07D235/18, C07D307/54, A61K31/415, A61K31/44
[1996/10]
CPC:
C07D295/155 (EP,US); C07D213/68 (EP,KR,US); A61P43/00 (EP);
A61P9/00 (EP); A61P9/06 (EP); A61P9/10 (EP);
C07D211/42 (EP,US); C07D211/44 (KR); C07D211/58 (EP,US);
C07D213/56 (EP,US); C07D231/12 (EP,US); C07D233/56 (EP,US);
C07D235/18 (EP,US); C07D249/08 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1996/10]
TitleGerman:Heterocyclyl-benzoylguanidine[1996/10]
English:Heterocyclic substituted benzoylguanidine[1996/10]
French:Hétérocyclyl-benzoylguanidines.[1998/20]
Former [1996/10]Benzoylguanidines, heterocyclyques substitués
Examination procedure06.08.1996Examination requested  [1996/40]
12.06.1997Despatch of a communication from the examining division (Time limit: M04)
24.09.1997Reply to a communication from the examining division
20.01.1998Despatch of a communication from the examining division (Time limit: M04)
06.02.1998Reply to a communication from the examining division
24.04.1998Despatch of communication of intention to grant (Approval: Yes)
09.07.1998Communication of intention to grant the patent
15.09.1998Fee for grant paid
15.09.1998Fee for publishing/printing paid
Opposition(s)08.10.1999No opposition filed within time limit [1999/52]
Fees paidRenewal fee
08.08.1997Renewal fee patent year 03
10.08.1998Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DY]EP0416499  (HOECHST AG [DE]) [DY] 1-8* column W *;
 [Y]EP0556673  (HOECHST AG [DE]) [Y] 1-8 * siehe Seite 6, Zeile 50 und Seite 7, Zeile 15, und Beispielen 8,12,15,18 *;
 [Y]EP0556674  (HOECHST AG [DE]) [Y] 1-8 * the whole document *;
 [PXY]EP0640588  (HOECHST AG [DE]) [PX] 1,3-8 * siehe Beispiel 15 * * column W * [PY] 1-8;
 [PXY]EP0667341  (MERCK PATENT GMBH [DE]) [PX] 1,3-8 * siehe Beispiel 10 * * the whole document * [PY] 1-8
 [A]  - R. KRANZHÖFER, "Suppression of Neointimal Thickening and smooth muscle cell proliferation", CIRC. RES., vol. 73, no. 2, pages 264 - 268 [A] 1-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.